ATRC AtriCure, Inc.: institutional ownership and insider trading
281 funds reported holding $1.71B of AtriCure, Inc. in their latest 13F filings; in Q2 2026 funds net bought $71.7M, with 51 new positions and 23 funds selling out; over the last 12 months insiders bought $0 and sold $4.37M on the open market; over its last four quarters it reported revenue of $570M and net income of $10.6M.
ATRC revenue and earnings
- Quarter ended Jun 30, 2026: revenue $154M, net income $8.96M, EPS 0.18
- Quarter ended Mar 31, 2026: revenue $141M, net income $108K, EPS 0.00
- Quarter ended Dec 31, 2025: revenue $141M, net income $1.76M, EPS 0.04
- Quarter ended Sep 30, 2025: revenue $134M, net income −$267K, EPS -0.01
Famous investors holding ATRC
- Two Sigma (Two Sigma Investments): $14.7M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $6.55M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $2.14M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $5.40M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $5.28M, 0.0% of the portfolio
Largest institutional holders of ATRC
- VANGUARD GROUP INC — $194M
- BlackRock, Inc. (BLK) — $125M
- WELLINGTON MANAGEMENT GROUP LLP — $97.8M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $87.5M
- Hood River Capital Management LLC — $81.3M
- ALLIANCEBERNSTEIN L.P. — $79.0M
- VANGUARD CAPITAL MANAGEMENT LLC — $61.3M
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. — $48.5M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $44.7M
- STATE STREET CORP (STT, STT-PG) — $38.9M
Recent ATRC insider trades
- Sep 23, 2026: Privitera Salvatore sold 4,519 shares ($271K)
- Sep 11, 2026: Groves Regina E sold 5,313 shares ($288K)
- Sep 8, 2026: Privitera Salvatore sold 3,657 shares ($201K)
- Sep 2, 2026: Privitera Salvatore sold 7,763 shares ($408K)
Members of Congress trading ATRC
- Sep 29, 2026: Gilbert Ray Cisneros, Jr. sold part of $1.00K–$15.0K
- Aug 20, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Mar 3, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- May 6, 2025: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Jul 19, 2024: Josh Gottheimer bought $1.00K–$15.0K
- Jun 18, 2024: Josh Gottheimer sold $1.00K–$15.0K
5%+ owners
- BlackRock, Inc.: 15.4% (Schedule 13G/A, filed Oct 5, 2026)
- Wellington Management Group LLP: 6.8% (Schedule 13G/A, filed May 15, 2026)
- Vanguard Portfolio Management: 5.5% (Schedule 13G, filed Apr 28, 2026)
- AllianceBernstein L.P.: 5.5% (Schedule 13G/A, filed Aug 14, 2026)
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Apr 29, 2026)
Who owns the most ATRC stock?
The largest institutional holders of AtriCure, Inc. in the latest 13F filings are VANGUARD GROUP INC ($194M), BlackRock, Inc. (BLK) ($125M), WELLINGTON MANAGEMENT GROUP LLP ($97.8M).
Are insiders buying or selling ATRC?
Over the last 12 months insiders bought $0 and sold $4.37M of AtriCure, Inc. stock on the open market (SEC Form 4).
Which famous investors own ATRC?
Two Sigma, Renaissance Technologies, Ray Dalio, D. E. Shaw, Ken Griffin.
What was ATRC's revenue last quarter?
AtriCure, Inc. reported revenue of $154M for the quarter ended June 30, 2026, with net income of $8.96M.
Which ETFs hold ATRC?
39 ETFs and mutual funds hold it among their top 100 positions, including HRSIX, DCCAX, CHCCX, CIPNX.